|
| 37951531 | Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors. | Mol Cell Endocrinol | 2024 |
| 35946088 | Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors. | Int J Surg Pathol | 2023 |
| 37558687 | Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid. | Sci Rep | 2023 |
| 37892063 | Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues. | Diagnostics (Basel) | 2023 |
| 37057870 | Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15â¿¿412 tumors. | Pathol Int | 2023 |
| 36980510 | Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland. | Diagnostics (Basel) | 2023 |
| 37379306 | CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas. | PLoS One | 2023 |
| 36649695 | GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors. | Pathobiology | 2023 |
| 36683495 | PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples. | Cancer Biomark | 2023 |
| 36728364 | High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer. | Appl Immunohistochem Mol Morphol | 2023 |
| 36269681 | Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors. | APMIS | 2023 |
| 35917493 | SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15â¿¿000 Tumors. | Arch Pathol Lab Med | 2023 |
| 34559291 | Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications. | Virchows Arch | 2022 |
| 35550834 | Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathology. | Hum Pathol | 2022 |
| 35477165 | Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors. | Pathobiology | 2022 |
| 35764407 | Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma. | Int J Immunopathol Pharmacol | 2022 |
| 35642329 | DOG1 overexpression is associated with mismatch repair deficiency and BRAF mutations but unrelated to cancer progression in colorectal cancer. | Histol Histopathol | 2022 |
| 35390310 | Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. | Exp Mol Pathol | 2022 |
| 35862385 | High prevalence of p16 staining in malignant tumors. | PLoS One | 2022 |
| 35449481 | Correction to: MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes. | Ann Surg Oncol | 2022 |
| 35872365 | Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer. | Pathol Res Pract | 2022 |
| 36137400 | Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumors. | Pathol Res Pract | 2022 |
| 35866621 | Villin expression in human tumors: a tissue microarray study on 14,398 tumors. | Expert Rev Mol Diagn | 2022 |
| 35992051 | Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors. | Anal Cell Pathol (Amst) | 2022 |
| 36029589 | Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors. | Ann Diagn Pathol | 2022 |
| 36292206 | Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells. | Diagnostics (Basel) | 2022 |
| 35921917 | Synaptophysin and chromogranin A expression analysis in human tumors. | Mol Cell Endocrinol | 2022 |
| 36289769 | Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 Tumors. | Biomedicines | 2022 |
| 35951102 | FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors. | Virchows Arch | 2022 |
| 36375372 | Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors. | Pathol Res Pract | 2022 |
| 34889867 | Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas. | Am J Surg Pathol | 2022 |
| 32303902 | High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma. | World J Urol | 2021 |
| 33797012 | Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer. | Int Urol Nephrol | 2021 |
| 33628598 | Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer. | Cancer Biol Med | 2021 |
| 33494829 | p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors. | Biomark Res | 2021 |
| 33491944 | Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate Cancer. | Appl Immunohistochem Mol Morphol | 2021 |
| 33708836 | Y-chromosome loss is frequent in male renal tumors. | Ann Transl Med | 2021 |
| 33588765 | Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors. | Mol Med | 2021 |
| 33917081 | Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors. | Biomedicines | 2021 |
| 34944647 | Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 Tumours. | Biomedicines | 2021 |
| 34943588 | Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular Carcinoma. | Diagnostics (Basel) | 2021 |
| 34547930 | MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10â¿¿399 Tissue Samples. | Technol Cancer Res Treat | 2021 |
| 34425503 | Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor origin. | Ann Diagn Pathol | 2021 |
| 34717148 | DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples. | Pathol Res Pract | 2021 |
| 34414034 | DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness. | PeerJ | 2021 |
| 34102222 | Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors. | Hum Pathol | 2021 |
| 34148155 | Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients. | J Cancer Res Clin Oncol | 2021 |
| 34092167 | High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancer. | Acta Oncol | 2021 |
| 34363325 | Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors. | J Pathol Clin Res | 2021 |
| 34090526 | E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors. | Biomark Res | 2021 |